- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5025 - PyridazinesHydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/5025
Total number of patents in this class: 2712
10-year publication summary
|
145
|
154
|
149
|
204
|
189
|
192
|
223
|
294
|
291
|
171
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
54 |
| F. Hoffmann-La Roche AG | 7816 |
40 |
| Janssen Pharmaceutica N.V. | 3160 |
38 |
| Novartis AG | 10224 |
36 |
| Gilead Sciences, Inc. | 2226 |
36 |
| Takeda Pharmaceutical Company Limited | 2713 |
32 |
| Genentech, Inc. | 4113 |
29 |
| AstraZeneca AB | 2820 |
28 |
| Agios Pharmaceuticals, Inc | 225 |
28 |
| Pfizer Inc. | 3400 |
27 |
| Hoffmann-La Roche Inc. | 3804 |
26 |
| Boehringer Ingelheim International GmbH | 4487 |
25 |
| Nihon Nohyaku Co., Ltd. | 325 |
25 |
| Prelude Therapeutics, Incorporated | 147 |
24 |
| Amgen Inc. | 4431 |
21 |
| Vanderbilt University | 2025 |
20 |
| Merck Sharp & Dohme LLC | 3737 |
20 |
| Children's Hospital Medical Center | 745 |
18 |
| Incyte Corporation | 1066 |
18 |
| Remix Therapeutics Inc. | 87 |
18 |
| Other owners | 2149 |